KDA Group Announces Oncology Treatment Partnership

KDA Group Inc. (TSE:KDA) has released an update.

Pick the best stocks and maximize your portfolio:

KDA Group Inc. has announced a strategic partnership with Pharmacie Horizon Santé and Dr. Éric Poirier to enhance the management of oncology treatments through the Medherize platform. This collaboration aims to streamline outpatient breast cancer care by integrating pharmaceutical, medical, and technological expertise. The initiative seeks to improve treatment coordination and monitoring, making cancer care more efficient.

For further insights into TSE:KDA stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.